Blackstone’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Other funds holding MRNA
TP
Blackstone's MRNA Position: Q2 2026 in Review
Blackstone sold out of Moderna (MRNA) in Q2 2026, closing a stake of 12,613 shares — an estimated $641K sold.
Blackstone first reported a position in MRNA in Q3 2024 and held it in 7 quarters. The position peaked at $843K in Q3 2024. 791 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.
- Blackstone reported no remaining Moderna position as of Q2 2026 after selling out during the quarter.
- Blackstone sold 12,613 Moderna shares in Q2 2026, an estimated $641K.
- Blackstone first reported a position in Moderna in Q3 2024 and held it in 7 quarters.
- Blackstone's Moderna position peaked at $843K in Q3 2024.
- 791 funds tracked by Wall St. Rank held Moderna as of Q2 2026.
Based on Blackstone's 13F filing for Q2 2026, filed 14 Aug 2026.